Open AccessRivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve
Author(s) -
Hélio Penna Guimarães,
Renato D. Lópes,
Pedro Gabriel Melo de Barros e Silva,
Idelzuíta Leandro Liporace,
Roney Orismar Sampaio,
Flávio Tarasoutchi,
Conrado R. Hoffmann-Filho,
Rodrigo de Lemos Soares Patriota,
Tiago Luiz Luz Leiria,
Diana Lamprea,
Dalton Bertolim Précoma,
Fernando Antibas Atik,
Fábio Serra Silveira,
Fabio R. Farias,
Diogo O. Barreto,
Adail Paixão Almeida,
Alexandre Cabral Zilli,
João David de Souza Neto,
Margaret Assad Cavalcante,
Fernando A.M.S. Figueira,
Flávia Cristina Soares Kojima,
Lucas Petri Damiani,
Renato Hideo Nakagawa Santos,
Nanci Valeis,
Viviane Bezerra Campos,
José Francisco Kerr Saraiva,
Francisco Antônio Helfenstein Fonseca,
Ibraim Pinto,
Carlos Costa Magalhães,
João Fernando Monteiro Ferreira,
John H. Alexander,
Ricardo Pavanello,
Alexandre Biasi Cavalcanti,
Otávio Berwanger
Publication year - 2020
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa2029603
Subject(s) - rivaroxaban , atrial fibrillation , medicine , cardiology , mitral valve , warfarin
The effects of rivaroxaban in patients with atrial fibrillation and a bioprosthetic mitral valve remain uncertain.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom